3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
3
Glioblastoma
3
Colorectal Neoplasms
3
Skin Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Hot Flashes
2
Vulvodynia
1
Thromboembolism
1
Severe Acute Respiratory Syndrome
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Hemorrhage
1
Pleural Effusion, Malignant
1
Platinum Resistant Ovarian Cancer
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Neutropenia
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
telapristone acetate
13
estradiol, norethindrone drug combination
9
elagolix
7
Estradiol
7
relugolix
6
Norethindrone Acetate
5
vilaprisan
4
ulipristal acetate
4
Sugars
3
Uterine Myomectomy
2
Lidocaine
2
Leuprolide
2
Letrozole
2
ulipristal
1
epigallocatechin gallate
1
Vitamin B 6
1
Uterine Artery Embolization
1
Tranexamic Acid
1
Therapeutics
1
Standard of Care
1
Sodium Chloride
1
Ropivacaine
1
Rocuronium
1
Progesterone
1
Pregabalin
1
Morphine
1
Misoprostol
1
Mifepristone
1
Injections, Subcutaneous
1
Ibuprofen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Leiomyoma
×
Sodium Chloride
×
Clear all
NCT04655144
2026-01-07
Dex-Fib
University of Miami
Phase 3
Completed
42 enrolled
9 charts